Clinical Trials in Los Angeles

Showing 3101-3120 of 16,901 trials

A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer

NCT04315701

This phase II trial studies how well cemiplimab before surgery works in treating patients with skin cancer that is high-risk and has not spread to other parts of the body (localized), has come back locally (locally recurrent), or has spread regionally (regionally advanced), and can be removed by surgery (resectable). Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

Recurrent Skin Squamous Cell CarcinomaResectable Skin Squamous Cell CarcinomaStage I Skin Cancer+2 more

University of Southern California35 participantsStarted Jun 2020

Los Angeles, California, United States • Los Angeles, California, United States • Newport Beach, California, United States +2 more locations

TERMINATEDPhase 2< 1 mile

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

NCT02316548

This randomized phase II trial studies the side effects and how well postoperative intensity modulated radiotherapy works after surgery in treating patients with urothelial bladder cancer. Radiation therapy uses high energy x-rays to kill tumor cells left behind in the pelvis after surgery. It is not yet known whether surgery followed by radiotherapy is more effective than surgery alone in treating patients with urothelial bladder cancer.

Stage III Bladder CancerStage IV Bladder Cancer

NRG Oncology14 participantsStarted Feb 2015

Bakersfield, California, United States • Greenbrae, California, United States • Los Angeles, California, United States +124 more locations

A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

Find Trials by Condition in Los Angeles

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

Allergic Disease Onset Prevention Study

Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

Mobile Self-Tracking of Mental Health

Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT

Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease